We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Small Abdominal Aortic Aneurysms Should Not Be Treated Surgically

By HospiMedica International staff writers
Posted on 24 Jun 2010
Patients with abdominal aortic aneurysms (AAAs) of less than 5.5 cm have no significant differences in clinical outcomes after endovascular repair (EVAR) than those with larger AAAs, according to a new study.

Researchers from Washington University School of Medicine (St. More...
Louis, MO, USA) evaluated five-year data from 156 patients enrolled in the prospective Medtronic (Santa Rosa, CA, USA) Talent Enhanced Low Profile System (eLPS) trial; analyses were performed for patients with AAAs that measured less than 5.5 cm, and for those with AAAs larger than 5.5 cm. Aneurysm morphology, demographics, and perioperative endpoints were assessed. Safety and effectiveness endpoints were evaluated at 30 days, one year, and five years after the procedures.

The results showed there were no statistically significant differences between large or small AAAs in the rate of freedom from major adverse events (84.6% versus 75.8%) or freedom from aneurysm-related mortality (98.7% versus 96.8%) at one year; long term outcomes at 5 years also showed no difference. The researchers did find that small AAA patients had higher rate of successful aneurysm treatment at 12 months (96.8% versus 84.9%), defined by the study as the combination of technical success, absence of aneurysm expansion, and absence of reintervention for type I or type III endoleaks. The study results were presented at the 64th Vascular Annual Meeting of the Society for Vascular Surgery (SVS), held during June 2010 in Boston (MA, USA).

"The results confirm the intuitive notion that smaller AAAs have aortic neck characteristics that are more favorable for EVAR. However, the important take-home message is that there were no differences in long-term 5-year outcomes between the two groups,” said lead author and study presenter Jeffrey Jim, M.D., of the section of vascular surgery. "So our position remains that EVAR should not be routinely recommended for those with small AAAs.”

AAA is a localized dilatation (ballooning) of the abdominal aorta exceeding the normal diameter by more than 50%. Approximately 90% of abdominal aortic aneurysms occur infrarenally but they can also occur pararenally or suprarenally. Such aneurysms can extend to include one or both of the iliac arteries in the pelvis. The major complication of abdominal aortic aneurysms is rupture, which can be life threatening, as large amounts of blood spill into the abdominal cavity, and can lead to death within minutes.

Related Links:

Washington University School of Medicine
Medtronic




Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.